-
Arvinas Announces Proposed Offering of Common Stock
Post on 12/14/20
-
Rocket Pharmaceuticals Closes Public Offering
Post on 12/14/20
-
Seelos Therapeutics Raises $10 Million
Post on 12/14/20
-
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
Post on 12/14/20
-
TG Therapeutics Proposed Public Offering of Common Stock
Post on 12/14/20
-
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Post on 12/14/20
-
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Post on 12/14/20
-
HOOKIPA Pharma Closes Public Offering of $80.9M of Common Stock
Post on 12/13/20
-
MetLife Authorized $3 Billion Share Repurchase
Post on 12/11/20
-
MetLife to Sell Auto & Home Business to Zurich Insurance Group Subsidiary Farmers Group for $3.94 Billion
Post on 12/11/20
-
Akari Therapeutics Reports Third Quarter 2020 Financial Results
Post on 12/11/20
-
3 Reasons to Buy Pfizer Stock Now
Post on 12/11/20
-
What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?
Post on 12/11/20
-
FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine
Post on 12/11/20
-
Cityblock Health Raises $160M Series C
Post on 12/10/20
-
Rocket Pharmaceuticals Prices Upsized Public Offering of Common Stock
Post on 12/10/20
-
Cityblock Health Raises $160M in Series C Funding
Post on 12/10/20
-
Gilead Sciences to Buy MYR GmbH for $1.15 Billion
Post on 12/10/20
-
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
Post on 12/10/20
-
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
Post on 12/10/20
-
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Post on 12/10/20
-
Is Johnson & Johnson a Great Dividend Stock?
Post on 12/10/20
-
Could Pfizer Be a Millionaire-Maker Stock?
Post on 12/10/20
-
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
Post on 12/9/20
-
Conversion Labs Approved for Nasdaq Capital Market Listing
Post on 12/9/20
New York
